Electromagnetic transduction therapy

Intervention

1 paper2 findings

  • 1 lab
  • 1 finding against
  • Cells1

Outcomes

1

Senescence-associated beta-galactosidase

upin human cells1downin human cells1

1 study
  1. Electromagnetic transduction therapy increases senescence-associated beta-galactosidase in human cells.

    “Contrastingly, 80 mT EMTT increased SA-β-Gal activity unless counteracted by 60% HDFCM.”

    Cellsunless counteracted by 60% human dermal fibroblast-conditioned mediumdermal fibroblast80 mT

    Effect of Dermal Fibroblast-Conditioned Media on Human Dermal Fibroblasts Treated With Electromagnetic Transduction Therapy

    Skin research and technology : official journal of International Society for Bioengineering and the Skin (ISBS) [and] International Society for Digital Imaging of Skin (ISDIS) [and] International Society for Skin Imaging (ISSI)1 Oct 2026

  2. Electromagnetic transduction therapy decreases senescence-associated beta-galactosidase in human cells.

    “SA-β-Gal activity, minimal in young cells, was elevated in aged HDFs, but was reduced by 40 mT EMTT with or without HDFCM.”

    Cellswith or without human dermal fibroblast-conditioned mediumdermal fibroblast40 mT

    Effect of Dermal Fibroblast-Conditioned Media on Human Dermal Fibroblasts Treated With Electromagnetic Transduction Therapy

    Skin research and technology : official journal of International Society for Bioengineering and the Skin (ISBS) [and] International Society for Digital Imaging of Skin (ISDIS) [and] International Society for Skin Imaging (ISSI)1 Oct 2026

More on Senescence-associated beta-galactosidase

Latest

Nov 2025: 0Dec 2025: 0Jan 2026: 0Feb 2026: 0Mar 2026: 0Apr 2026: 0May 2026: 0Jun 2026: 0Jul 2026: 0Aug 2026: 0Sep 2026: 0Oct 2026: 11 in 12 months